Quantum Biopharma (TSE:QNTM) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Quantum BioPharma Ltd. announces a non-brokered private placement of convertible debenture units, aiming to raise up to $5 million for business development and working capital. The debenture units, priced at $1,000 each, offer attractive terms including a 1.25% monthly interest and conversion options into class B shares. The offering is expected to close in tranches starting the week of December 9, 2024.
For further insights into TSE:QNTM stock, check out TipRanks’ Stock Analysis page.
